NCT05294029 Neuro-Orthopaedic Disorders During Aging in Patients With Neuromotor Disability
| NCT ID | NCT05294029 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Institut de Sante Parasport Connecte Synergies |
| Condition | Disability or Chronic Disease Leading to Disablement |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,000 participants |
| Start Date | 2022-05-01 |
| Primary Completion | 2032-02-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,000 participants in total. It began in 2022-05-01 with a primary completion date of 2032-02-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
People with neuromotor disability (i.e. following an inborn or acquired spinal cord, cerebral or peripheral neurological lesion) are at risk of worsening their neuro-orthopaedic disorders during aging, including fracture risk. Nevertheless, at the present time, the natural evolution of their neuro-orthopedic disorders and the long-term functional impact of their medical and surgical treatments is unknown. The aim of this study is to describe neuro-orthopedic disorders during aging of patients with neuromotor disability, their functional repercussions, their comorbidities and the therapeutic strategies used.
Eligibility Criteria
Inclusion Criteria: * Patients \>= 18 years old ; * Treated in the Neuro Orthopaedic Unit (UPOH) of the Physical Medicine and Rehabilitation Department of our university hospital ; * Having a neuromotor disability ; * No opposition to be enrolled in the study from the patient, or from a legally authorized close relative if the patient's state of health does not allow it ; * Affiliation to a social security scheme. Exclusion Criteria: * Under court protection.
Contact & Investigator
François Genêt, MD-PhD
PRINCIPAL INVESTIGATOR
Department of Physical Medicine and Rehabilitation, Raymond Poincaré Hospital, AP-HP, 92380 Garches, France
Frequently Asked Questions
Who can join the NCT05294029 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Disability or Chronic Disease Leading to Disablement. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05294029 currently recruiting?
Yes, NCT05294029 is actively recruiting participants. Contact the research team at francois.genet@aphp.fr for enrollment information.
Where is the NCT05294029 trial being conducted?
This trial is being conducted at Garches, France.
Who is sponsoring the NCT05294029 clinical trial?
NCT05294029 is sponsored by Institut de Sante Parasport Connecte Synergies. The principal investigator is François Genêt, MD-PhD at Department of Physical Medicine and Rehabilitation, Raymond Poincaré Hospital, AP-HP, 92380 Garches, France. The trial plans to enroll 2,000 participants.